Healthcare and Life Sciences

Format: 2017-01-19
Format: 2017-01-19

Overview of the global hospital-acquired urinary tract infection testing market

Technavio’s market research analyst predicts the global hospital-acquired urinary tract infection testing market to grow at a CAGR of around 19% between 2016 and 2020. Urinary tract infection occupies the largest share in the HAIs category, and the number is constantly growing. This has encouraged several vendors to develop innovative testing products that will subsequently augment the demand for hospital-acquired urinary tract infection testing products. Several technological advancements have enhanced the testing procedures for urinary tract infection, as they are more precise, sensitive, generate faster outcomes, and provide a broader range of pathogen detection as compared with the most traditional methods. Moreover, the innovative techniques in bioinformatics and software programs help manage a massive amount of data and offer better-quality results from tests such as molecular diagnostics. These methods provide initiation of infection control practices, optimization of treatment selection, reduced hospital stay, and improved surveillance of infectious diseases. Also, hospitals are setting up infection control committees that focus on only HAIs. Such infection control committee is responsible for the evaluation and planning of evidence-based practice, resource allocation, and prioritization of matters related to infection control.

Geographically, the Americas dominated the market and accounted for the largest market share in 2015. The high prevalence of infectious diseases, leading to the increased demand for diagnostic products and services and focus on disease management has propelled market growth in this region. The US is the largest revenue contributor for the hospital-acquired UTI testing market in the Americas owing to the massive sales of


November 28, 2016 | 90 Pages | SKU: IRTNTR10934

Overview of the global peripheral vascular diagnostic systems market

The global peripheral vascular diagnostic systems market is anticipated to grow at a steady rate and will post a CAGR of more than 7% during the forecast period. The increasing availability of specialized cardiology and vascular specialists across the globe will drive the growth prospects for the global peripheral vascular diagnostic systems market until the end of 2020. A number of skilled cardiologists or vascular specialists are opting for non-invasive diagnostics to treat various cardiovascular diseases (CVD) and peripheral artery diseases (PAD) in various hospitals and cardiac centers. These procedures are carried out after and before angioplasty procedures are performed. Furthermore, one of the well-known established cardiology procedures called diagnostic angiography and coronary stenting must be performed by vascular specialists. At present, the physicians prefer non-invasive diagnostic techniques over the angiography, a minimally invasive technique, to monitor the individuals. In addition, many vendors are expanding their businesses in various developing countries. Since the number of experienced surgeons is increasing in developing countries, the demand for an angioplasty balloons technique for treating CADs is also increasing. Furthermore, vendors are also conducting medical education programs and practice sessions to train surgeons in surgical techniques and device implantation.

In terms of geography, the Americas accounted for the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major reasons for the rising demand of peripheral vascular diagnostic systems in the region is the increasing number of patients suffering from PAD and diabetes. These diseases further increase the risk of heart attack in the country. Other factors that drive the market’s growth in the region


November 28, 2016 | 86 Pages | SKU: IRTNTR10937

Overview of the global hearing aids market

The global hearing aids market is anticipated to grow at a steady rate and will post a CAGR of more than 5% during the forecast period. The increased use of binaural fittings will drive the growth prospects for the global hearing aids market during the forecast period. The bilateral hearing loss is a condition where a patient suffers from hearing the loss in both the ears, so the patients who have bilateral hearing loss are recommended to use the binaural fittings. Furthermore, these devices help to experience better sound from all directions in comparison to the single hearing aid devices. Also, they help in speech recognition in noisy environments and enable the patients to have a wider hearing range with improved sound identification. Binaural devices have the potential to keep and maintain both the ears in an active condition. Moreover, the use of binaural hearing aids is increasing in various countries such as Germany, France and the UK.

In terms of geography, the Americas accounted for the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major factors leading to market’s growth is the increasing presence of government advisors and funding, which increases the growth opportunities in the market. Since the excessive noise pollution has increased the patient pool in the US, it is one of the regions which is witnessing a strong market growth in the hearing aids market. Also, another set of factors that boosts the market’s growth is the integration of hearing aid devices with Bluetooth connectivity, and Wi-Fi enabled devices.

Competitive landscape and key vendors

The global hearing aids market is highly fragmented due to the presence of large medium and small-sized companies. The technological advancements and product upgradation will intensify the competitive


November 25, 2016 | 124 Pages | SKU: IRTNTR10904

Overview of the global next-generation biologics market

According to the market research analysts at Technavio, the next-generation biologics market is anticipated to witness staggering growth and will post a staggering CAGR of more than 14% during the forecast period. The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies. Therefore, in the recent years, antibodies have become the preferred choice to treat respiratory, oncology, and inflammatory diseases. The use of ADCs, including radioimmunotherapy and antibody-directed enzyme prodrug therapy, has increased significantly. The augmented use of these antibodies in drug development increases revenue generation in the global next-generation biologics market, thereby contributing to market growth.

One of the recent trends gaining traction in the market is the emergence of targeted and combination therapies for the treatment of various diseases such as viral infections and cancer. This is mainly because targeted therapies have fewer side effects than conventional non-targeted therapies. Combination therapies work by targeting multiple mechanisms simultaneously. Targeting multiple pathways in diseases such as cancer, reduce the risk of developing treatment-resistant disorders. As a result, combination therapies, which target distinct mechanisms, are highly efficacious in treating various diseases, which will boost this market’s growth over the next four years.


November 24, 2016 | 99 Pages | SKU: IRTNTR10913

Overview of the global gastrointestinal stents market

The global gastrointestinal stents market is anticipated to grow at a steady rate and will post a CAGR of close to 4% during the forecast period. The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global industrial castings market during the forecast period. Generally, MI surgeries have low-risk complications and other benefits such as reduced costs, shorter hospital stay, faster recovery, lesser pain, fewer post-surgery infections, reduced incision marks, bleeding control, minimal complications, and heightened accuracy. Furthermore, MI techniques are highly preferred by the patients suffering from gastrointestinal diseases. For instance, a minimally invasive surgery is performed on stenosis using non-vascular stents. The gastrointestinal stent interventions do not involve any blood vessels. In addition, the imaging technologies are used to guide instruments inside the body by the surgeons without any surgery. Also, with the advent of non-vascular intervention for stenosis, the number of surgical procedures conducted each year to treat various vascular ad non-vascular diseases has increased. Moreover, improvements made in the equipment handling has transformed surgical procedures by providing better flexibility, support, and tracking of the stent during the procedure.

In terms of geography, the Americas occupied the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major reasons responsible for the market’s growth in the region is the high incidence of gastrointestinal disorders and chronic diseases such as colorectal cancer, rectal cancer, and severe abdominal diseases medical conditions. Another factor spurring this growth is the rapid shift from open surgical therapy to endovascular procedures with technologically advanced devices.


November 24, 2016 | 87 Pages | SKU: IRTNTR10903

Overview of the travel vaccines market

Technavio’s market research analysts have predicted that the global travel vaccines market is likely to witness fast-paced growth and will post a CAGR of close to 7% during the forecast period. The introduction of additional age group coverage is one of the primary factors driving this market’s growth. While approving a vaccine, the regulatory authorities also specify the age group approved for receiving the vaccine. This age group is specified on the vaccine label and is based on the efficacy and safety results obtained from clinical trials conducted using individuals from these age groups. Label expansion to include additional age groups approved for immunization requires additional regulatory approval. These approvals are based on the additional clinical trials conducted using individuals from additional age groups. The increase in approvals for additional age group coverage will increase the patient population for the vaccine, thereby propelling this market’s growth in the coming years.

One of the latest trends gaining traction in the market is the introduction of combination vaccines for travelers. Combination vaccines for immunizing travelers target multiple causative agents, which helps in the prevention of infectious diseases such as meningococcal disease, Japanese encephalitis, and hepatitis A infection. Moreover, combination vaccines eliminate the need for administering separate vaccines. For instance, pediatric hexavalent combination vaccine V419 is currently under review by the US FDA and MenABCWY polysaccharide conjugated vaccine is currently under Phase II stage of development for the prevention of meningococcal infections.


Pages